Routine Use of RUSH Protocol in the Intensive Care Unit - Trial NCT06361225
Access comprehensive clinical trial information for NCT06361225 through Pure Global AI's free database. This phase not specified trial is sponsored by Meir Medical Center and is currently Not yet recruiting. The study focuses on RUSH Protocol. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Meir Medical Center
Timeline & Enrollment
N/A
Aug 01, 2024
Aug 01, 2025
Primary Outcome
Change of patient medical therapy,Performing unplanned laboratory tests,Performing unplanned image tests,Performing unplanned invasive procedure
Summary
The RUSH protocol has been used for several years for the rapid evaluation of a patient
 admitted to the emergency room with shock. Traditionally, its use was especially common in
 trauma victims, but later its use was extended to patients admitted to the emergency room
 with shock from any reason. The protocol includes rapid assessment with the guideness of
 ultrasound of heart contraction, assessment for pleural effusions, assessment of
 intra-abdominal blood (FAST), diagnosis of venous thrombosis (DVT), and rulling out
 hydronephrosis. It can also add a pupil size assessment and an evaluation of the gallbladder
 and bile ducts, as well as the size of the bladder. In intensive care, we use this protocol
 (or part of it) for the evaluation of a patient who is deteriorating in the ICU for an
 unknown reason . In some patients we use this protocol as a routine part of the physical
 examination as part of the daily patient evaluation.
 
 We would like to investigate whether the routine use of the RUSH protocol as part of the
 daily patient evaluation in the general intensive care unit will lead to any change in the
 patient's management.
Data Source
ClinicalTrials.gov
NCT06361225
Non-Device Trial

